Granular Growth: A CRISPR Technology Market Segment Analysis of Tools, Services, and Therapeutics
To truly understand the gene-editing industry, one must look at its three primary pillars: tools, services, and therapeutics. In 2026, the "tools" segment—which includes the sale of Cas proteins, guide RNAs, and delivery kits—is the most stable and provides the necessary foundation for all other research. Companies like Thermo Fisher and Merck KGaA have optimized their supply chains...
0 Comments 0 Shares 547 Views 0 Reviews